Viz.ai

United States - San Francisco, CA

• 07/04/2022
• Series D
• $100,000,000

Viz.ai, located in San Francisco, Tel Aviv, Portugal and Amsterdam, pioneered the use of AI algorithms and machine learning to increase the speed of diagnosis and care for a variety of acute and emergent diseases across hospitals and health systems.

The Viz Platform is a transformative, intelligent care coordination solution that unifies synchronized care collaboration, high fidelity mobile image viewing, automated workflows and improved visibility at decision-making moments. Viz.ai’s comprehensive neurovascular and vascular AI platform is clinically proven to save time and improve patient outcomes and access to care and is used in more than 1,000 hospitals in the US and EMEA.

Viz.ai’s life science portfolio expands the power of the AI-powered Viz Platform to pharmaceutical and medical device companies who are leaning into digital transformation to bring life-saving therapies to market more efficiently.

The company was named to the Forbes 2021 Next Billion-Dollar Startups list of the 25 fastest-growing venture-backed startups and has been on the Forbes AI 50 list for three consecutive years. For more information visit viz.ai.

Related People

Dr Chris MansiCo Founder

United States - San Francisco Bay Area

Clinician innovator, entrepreneur and optimist. I care about healthcare access, building and supporting great teams, transformative technologies, and improving provider experience to effect and scale better patient outcomes. Heading up Viz.ai, an applied AI healthcare company, is how I get to work on these things everyday, with our focus on building frictionless clinician-facing products that enable and refocus their time on the job to be done: providing the best care to patients, everytime, everywhere.

LinkedIn https://www.linkedin.com/in/chrismansimd/